Arcus Biosciences, Inc. - Common Stock (RCUS)
CUSIP: 03969F109
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 122,470,452
- Total 13F shares
- 50,826,972
- Share change
- +2,556,759
- Total reported value
- $2,056,609,533
- Put/Call ratio
- 160%
- Price per share
- $40.47
- Number of holders
- 136
- Value change
- +$107,109,155
- Number of buys
- 72
- Number of sells
- 65
Quarterly Holders Quick Answers
What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969F109:
Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC |
13F
|
Company |
4.2%
|
5,122,359
|
$178,617,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.4%
|
4,202,960
|
$146,558,000 | — | 30 Sep 2021 | |
| Alphabet Inc. |
13F
|
Company |
3.3%
|
4,100,475
|
$142,984,000 | — | 30 Sep 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
2.8%
|
3,431,010
|
$119,639,000 | — | 30 Sep 2021 | |
| BVF INC/IL |
13F
|
Company |
2.6%
|
3,229,822
|
$112,624,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
2.5%
|
3,091,165
|
$107,789,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
2,466,479
|
$86,007,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
2,331,630
|
$81,304,000 | — | 30 Sep 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
2,084,883
|
$72,700,000 | — | 30 Sep 2021 | |
| Invus Financial Advisors, LLC |
13F
|
Company |
1.5%
|
1,842,077
|
$64,233,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
1.4%
|
1,699,113
|
$59,248,000 | — | 30 Sep 2021 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1.2%
|
1,501,228
|
$52,348,000 | — | 30 Sep 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
1,457,349
|
$50,818,000 | — | 30 Sep 2021 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.79%
|
970,164
|
$33,830,000 | — | 30 Sep 2021 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.64%
|
785,106
|
$27,377,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.64%
|
783,176
|
$27,309,000 | — | 30 Sep 2021 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.6%
|
739,010
|
$25,769,000 | — | 30 Sep 2021 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.53%
|
652,240
|
$22,744,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.52%
|
640,232
|
$22,325,000 | — | 30 Sep 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.38%
|
461,980
|
$16,109,000 | — | 30 Sep 2021 | |
| Bain Capital Public Equity Management II, LLC |
13F
|
Company |
0.37%
|
454,863
|
$15,861,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.29%
|
355,241
|
$12,388,000 | — | 30 Sep 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.24%
|
298,410
|
$10,406,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.24%
|
291,300
|
$10,158,000 | — | 30 Sep 2021 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.24%
|
291,003
|
$10,147,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
278,043
|
$10,118,000 | — | 30 Sep 2021 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.22%
|
272,607
|
$9,506,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.22%
|
269,359
|
$9,392,000 | — | 30 Sep 2021 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.19%
|
236,637
|
$8,252,000 | — | 30 Sep 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.18%
|
224,684
|
$7,834,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
220,393
|
$7,685,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.17%
|
202,501
|
$7,061,000 | — | 30 Sep 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.16%
|
192,963
|
$6,729,000 | — | 30 Sep 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.15%
|
186,178
|
$6,492,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
133,813
|
$4,667,000 | — | 30 Sep 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.1%
|
123,700
|
$4,313,000 | — | 30 Sep 2021 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.09%
|
104,848
|
$3,656,000 | — | 30 Sep 2021 | |
| Bellevue Group AG |
13F
|
Company |
0.08%
|
94,700
|
$3,302,000 | — | 30 Sep 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.07%
|
87,503
|
$3,051,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
85,896
|
$2,995,000 | — | 30 Sep 2021 | |
| Parallel Advisors, LLC |
13F
|
Company |
0.07%
|
84,983
|
$2,963,000 | — | 30 Sep 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.07%
|
82,330
|
$2,871,000 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.06%
|
75,000
|
$2,615,000 | — | 30 Sep 2021 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.06%
|
70,050
|
$2,443,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
68,665
|
$2,394,000 | — | 30 Sep 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.06%
|
68,445
|
$2,387,000 | — | 30 Sep 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
65,503
|
$2,284,000 | — | 30 Sep 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.05%
|
64,873
|
$2,262,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
62,485
|
$2,179,000 | — | 30 Sep 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.05%
|
61,780
|
$2,154,000 | — | 30 Sep 2021 |
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q4 2021
As of 31 Dec 2021,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,826,972 shares.
The largest 10 holders included
EcoR1 Capital, LLC, BlackRock Inc., PFM Health Sciences, LP, VANGUARD GROUP INC, BVF INC/IL, FMR LLC, Alphabet Inc., STATE STREET CORP, Octagon Capital Advisors LP, and Woodline Partners LP.
This page lists
136
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
127
Q4 2021 holders
136
Holder diff
9
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.